Prognostic value of serum C-reactive protein level prior to second-line treatment in intermediate risk metastatic renal cell carcinoma patients

被引：0
作者：
Kimiharu Takamatsu
Ryuichi Mizuno
Nobuyuki Tanaka
Toshikazu Takeda
Shinya Morita
Kazuhiro Matsumoto
Takeo Kosaka
Toshiaki Shinojima
Eiji Kikuchi
Hiroshi Asanuma
Masafumi Oyama
Shuji Mikami
Mototsugu Oya
机构：
[1] Keio University School of Medicine,Department of Urology
[2] Saitama Medical University International Medical Center,Department of Uro
[3] Keio University School of Medicine,Oncology
来源：
International Journal of Clinical Oncology | 2019年 / 24卷
关键词：
Renal cell carcinoma; Neoplasm metastasis; C-reactive protein; Biomarkers; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1069 / 1074
页数：5
相关论文
共 50 条
[21]   C-reactive protein as a prognostic marker for advanced renal cell carcinoma treated with sunitinib [J].
Fujita, Tetsuo ;
Iwamura, Masatsugu ;
Ishii, Daisuke ;
Tabata, Ken-ichi ;
Matsumoto, Kazumasa ;
Yoshida, Kazunari ;
Baba, Shiro .
INTERNATIONAL JOURNAL OF UROLOGY, 2012, 19 (10) :908-913
[22]   The prognostic value of C-reactive protein in renal cell carcinoma: A systematic review and meta-analysis [J].
Hu, Qingfeng ;
Gou, Yuancheng ;
Sun, Chuanyu ;
Ding, Weihong ;
Xu, Ke ;
Gu, Bin ;
Xia, Guowei ;
Ding, Qiang .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) :50.e1-50.e8
[23]   Prognostic value of the C-reactive protein/albumin ratio in patients with laryngeal squamous cell carcinoma [J].
Yu, Shi-tong ;
Zhou, Zhiwei ;
Cai, Qian ;
Liang, Faya ;
Han, Ping ;
Chen, Renhui ;
Huang, Xiao-ming .
ONCOTARGETS AND THERAPY, 2017, 10 :879-884
[24]   CaboPoint: a Phase II study of cabozantinib as second-line treatment in patients with metastatic renal cell carcinoma [J].
Albiges, Laurence ;
Schmidinger, Manuela ;
Taguieva-Pioger, Naila ;
Perol, David ;
Grunwald, Viktor ;
Guemas, Eric .
FUTURE ONCOLOGY, 2022, 18 (08) :915-925
[25]   Efficacy of Axitinib as Second-line Treatment in Locally Advanced and Metastatic Renal Cell Carcinoma [J].
Ueda, Kosuke ;
Suekane, Shigetaka ;
Hirano, Taishi ;
Ogasawara, Naoyuki ;
Chikui, Katsuaki ;
Uemura, Keiichiro ;
Nakiri, Makoto ;
Nishihara, Kiyoaki ;
Matsuo, Mitsunori ;
Igawa, Tsukasa .
ANTICANCER RESEARCH, 2018, 38 (09) :5387-5392
[26]   Impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma treated by second-line chemotherapy with gemcitabine, etoposide and cisplatin [J].
Saito, Kazutaka ;
Urakami, Shinji ;
Komai, Yoshinobu ;
Yasuda, Yosuke ;
Kubo, Yuichi ;
Kitsukawa, Shinichi ;
Okubo, Yuhei ;
Yamamoto, Shinya ;
Yonese, Junji ;
Fukui, Iwao .
BJU INTERNATIONAL, 2012, 110 (10) :1478-1484
[27]   C-reactive protein and neutrophil-lymphocyte ratio are prognostic in metastatic clear-cell renal cell carcinoma patients treated with nivolumab [J].
Roussel, Eduard ;
Kinget, Lisa ;
Verbiest, Annelies ;
Debruyne, Philip R. ;
Baldewijns, Marcella ;
Van Poppel, Hendrik ;
Albersen, Maarten ;
Beuselinck, Benoit .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (04) :239.e17-239.e25
[28]   Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma treated with first-line and subsequent second-line targeted therapy: A proposal of the modified-IMDC risk model [J].
Tanaka, Nobuyuki ;
Mizuno, Ryuichi ;
Yasumizu, Yota ;
Ito, Keiichi ;
Shirotake, Suguru ;
Masunaga, Ayako ;
Ito, Yujiro ;
Miyazaki, Yasumasa ;
Hagiwara, Masayuki ;
Kanao, Kent ;
Mikami, Shuji ;
Nakagawa, Ken ;
Momma, Tetsuo ;
Masuda, Takeshi ;
Asano, Tomohiko ;
Oyama, Masafumi ;
Oya, Mototsugu .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (02) :39.e19-39.e28
[29]   Racial disparity in preoperative C-reactive protein level for predicting prognosis of patients with non-metastatic clear cell renal cell carcinoma: INMARC study [J].
Chen, Wei ;
Tanaka, Hajime ;
Kobayashi, Masaki ;
Fukuda, Shohei ;
Nakayama, Akinori ;
Meagher, Margaret F. ;
Yoshida, Soichiro ;
Derweesh, Ithaar H. ;
Master, Viraj A. ;
Hirakawa, Akihiro ;
Fujii, Yasuhisa ;
Saito, Kazutaka .
INTERNATIONAL JOURNAL OF UROLOGY, 2025, :414-422
[30]   Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma [J].
Ito, Keiichi ;
Asano, Tomohiko ;
Yoshii, Hidehiko ;
Satoh, Akinori ;
Sumitomo, Makoto ;
Hayakawa, Masamichi .
INTERNATIONAL JOURNAL OF UROLOGY, 2006, 13 (11) :1365-1370
12345